5th Annual Project & Portfolio Management in the Pharmaceutical Industry (BALS82)
|Event Date/Time: Sep 17, 2009||End Date/Time: Sep 18, 2009|
In current highly regulated and limited resources environment, it is crucial to understand, how to build an optimal mix of innovative projects within a portfolio, bring them forward quickly and manage them effectively.
Reveal new approaches and tools for portfolio prioritization and project selection. Learn from first hand experience, how to select the best portfolio, measure and improve project & portfolio performance.
This event will bring together the experts from the pharmaceutical industry to benchmark their best practices in executing effective project & portfolio management.
Global Head Project Management, Novartis, USA
Quantitative & Decision Sciences, GlaxoSmithKline, UK
Head of Portfolio Office, Bayer Schering Pharma, Germany
Vice President Corporate Project Management R&D , Lundbeck, Denmark
Vice President, Head of Department Portfolio, Project & Alliance Management, Nycomed, Germany
Director Global Project Mgt BioSurgery, Baxter, Austria
Department Head Strategic Innovation & Research Portfolio Management, Merck Serono, Germany
Turning promising portfolios into profitable revenues â€“ maximizing the positive impact on corporate objectives and companyâ€™s results
Measuring & improving project & portfolio performance (quality & costs)
New approaches to portfolio prioritization & project selection â€“ benchmarking different tools (risk-reward grids, metrics, models & conceptsâ€¦)
Value drivers in portfolio management in a changing environment
Case studies on managing early stage discovery projects vs. late stage development projects â€“ operational level
Assessing & managing risk in projects & portfolio